safety and tolerability of lactobacillus reuteri dsm 17938 and effects on biomarkers in healthy adults results from a randomized masked trial这种乳酸菌的安全性和耐受性dsm 17938和影响生物标志物在健康成年人从随机的试验结果.pdfVIP

safety and tolerability of lactobacillus reuteri dsm 17938 and effects on biomarkers in healthy adults results from a randomized masked trial这种乳酸菌的安全性和耐受性dsm 17938和影响生物标志物在健康成年人从随机的试验结果.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
safety and tolerability of lactobacillus reuteri dsm 17938 and effects on biomarkers in healthy adults results from a randomized masked trial这种乳酸菌的安全性和耐受性dsm 17938和影响生物标志物在健康成年人从随机的试验结果

Safety and Tolerability of Lactobacillus reuteri DSM 17938 and Effects on Biomarkers in Healthy Adults: Results from a Randomized Masked Trial 1. 1. 1 2 1 Nisha Mangalat , Yuying Liu , Nicole Y. Fatheree , Michael J. Ferris , Melissa R. Van Arsdall , 3 3,4 1 2 1 Zhongxue Chen , Mohammad H. Rahbar , Wallace A. Gleason , Johana Norori , Dat Q. Tran , J. Marc Rhoads1* 1 Department of Pediatrics, University of Texas Medical School at Houston, Houston, Texas, United States of America, 2 Department of Pediatrics, Louisiana State University Health Science Center and The Research Institute for Children, New Orleans, Louisiana, United States of America, 3 Biostatistics/Epidemiology/Research Design Core, Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston, Houston, Texas, United States of America, 4 Division of Epidemiology, Human Genetics, and Environmental Sciences, The University of Texas School of Public Health at Houston, Houston, Texas, United States of America Abstract Background: There are few carefully-designed studies investigating the safety of individual probiotics approved under Investigational New Drug policies. Objectives: The primary aim of this prospective, double-blind placebo-controlled trial was to investigate if daily treatment of adults with Lactobacillus reuteri DSM 17938 (LR) for 2 months is safe and well-tolerated. Our secondary aim was to determine if LR treatment has immune effects as determined by regulatory T cell per

您可能关注的文档

文档评论(0)

xyz118 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档